Investigation of trends, hot spots and effective therapies for pregnancy outcomes in polycystic ovary syndrome: a bibliometric analysis - Summary - MDSpire
Advertisement
Investigation of trends, hot spots and effective therapies for pregnancy outcomes in polycystic ovary syndrome: a bibliometric analysis
To identify trends and key research areas in PCOS and pregnancy outcomes and synthesize effective treatment strategies for PCOS-related infertility.
Key Findings:
410 WOSCC publications and 45 PubMed clinical trials were included.
China and the United States were the leading contributors to the research.
Insulin resistance and metformin were identified as current research hotspots.
Emerging frontiers include neonatal outcomes, metabolic syndrome, and ovarian hyperstimulation syndrome.
Shanghai Jiao Tong University had the greatest output, while the University of Adelaide was the most cited institution.
Interpretation:
This bibliometric analysis provides a comprehensive overview of the research landscape in PCOS and pregnancy outcomes, highlighting significant areas for future investigation and their implications.
Limitations:
The analysis is limited to English-language publications.
Exclusion of non-research articles may overlook relevant insights.
Language restrictions may introduce bias in the findings.
Conclusion:
Future research should focus on insulin resistance mechanisms, metabolic syndrome management, and optimizing assisted reproductive technologies, including frozen embryo transfer and letrozole combination therapies.
A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.
